[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ATE163421T1 - Tocopherol-analoge mit cardioprotectiver wirkung - Google Patents

Tocopherol-analoge mit cardioprotectiver wirkung

Info

Publication number
ATE163421T1
ATE163421T1 AT92402656T AT92402656T ATE163421T1 AT E163421 T1 ATE163421 T1 AT E163421T1 AT 92402656 T AT92402656 T AT 92402656T AT 92402656 T AT92402656 T AT 92402656T AT E163421 T1 ATE163421 T1 AT E163421T1
Authority
AT
Austria
Prior art keywords
cardioprotection
effects
tocopherol analogues
tocopherol
analogues
Prior art date
Application number
AT92402656T
Other languages
English (en)
Inventor
J Martin Grisar
Margaret A Petty
Frank Bolkenius
Original Assignee
Merrell Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Pharma Inc filed Critical Merrell Pharma Inc
Application granted granted Critical
Publication of ATE163421T1 publication Critical patent/ATE163421T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/655Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
    • C07F9/6552Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a six-membered ring
    • C07F9/65522Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a six-membered ring condensed with carbocyclic rings or carbocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Rheumatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Inspection Of Paper Currency And Valuable Securities (AREA)
  • Cosmetics (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Noodles (AREA)
  • Credit Cards Or The Like (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Photoreceptors In Electrophotography (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Fire-Detection Mechanisms (AREA)
  • Absorbent Articles And Supports Therefor (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
AT92402656T 1991-10-02 1992-09-29 Tocopherol-analoge mit cardioprotectiver wirkung ATE163421T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP91402630A EP0535283A1 (de) 1991-10-02 1991-10-02 Tocopherol Analoge mit kardioprotektiver Wirkung

Publications (1)

Publication Number Publication Date
ATE163421T1 true ATE163421T1 (de) 1998-03-15

Family

ID=8208620

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92402656T ATE163421T1 (de) 1991-10-02 1992-09-29 Tocopherol-analoge mit cardioprotectiver wirkung

Country Status (17)

Country Link
EP (2) EP0535283A1 (de)
JP (1) JP3230699B2 (de)
KR (1) KR100253108B1 (de)
AT (1) ATE163421T1 (de)
AU (1) AU652077B2 (de)
CA (1) CA2079289C (de)
DE (1) DE69224501T2 (de)
DK (1) DK0536036T3 (de)
ES (1) ES2115656T3 (de)
FI (1) FI105552B (de)
GR (1) GR3026242T3 (de)
HU (1) HU215123B (de)
IL (1) IL103305A0 (de)
NO (1) NO923840L (de)
NZ (1) NZ244549A (de)
TW (1) TW224970B (de)
ZA (1) ZA927429B (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5510373A (en) * 1992-04-06 1996-04-23 Merrell Pharmaceuticals Inc. Cardioprotective agents
US5721233A (en) * 1992-04-06 1998-02-24 Merrell Pharmaceuticals Inc. Derivatives of 2,3-dihydro benzofuranols
US5545660A (en) * 1992-04-07 1996-08-13 Merrell Pharmaceuticals Inc. Hydrazide derivatives of 3,4-dihydro-2H-1-benzopyrans
WO1999026954A1 (en) * 1997-11-25 1999-06-03 University Of Otago Mitochondrially targeted antioxidants
AUPR549901A0 (en) 2001-06-06 2001-07-12 Vital Health Sciences Pty Ltd Topical formulation containing tocopheryl phosphates
CN1547475B (zh) 2001-07-27 2010-12-15 生命健康科学有限公司 含电子转移试剂的磷酸酯衍生物的皮肤制剂
DE50212837D1 (de) * 2002-06-19 2008-11-13 Cognis Ip Man Gmbh Verwendung von Wirkstoffgemischen zur Herstellung eines Medikamentes gegen rheumatische Arthritis
AU2002950713A0 (en) 2002-08-09 2002-09-12 Vital Health Sciences Pty Ltd Carrier
US7888334B2 (en) 2003-08-22 2011-02-15 Antipodean Pharmaceuticals, Inc. Mitoquinone derivatives used as mitochondrially targeted antioxidants
KR101003960B1 (ko) 2003-08-22 2010-12-30 안티포딘 파마슈티칼스, 인코포레이티드 미토콘드리아 표적화 산화방지제로서 사용되는 미토퀴논 유도체를 포함하는 약제학적 조성물
WO2005032544A1 (en) 2003-09-19 2005-04-14 Galileo Pharmaceuticals, Inc. Treatment of mitochondrial diseases
AU2005202477B2 (en) 2004-03-03 2005-12-15 Vital Health Sciences Pty Ltd Alkaloid formulations
ES2557475T3 (es) 2005-06-17 2016-01-26 Vital Health Sciences Pty Ltd. Un portador que comprende uno o más derivados di- y/o monofosfato de agentes de transferencia de electrones
US7813042B2 (en) 2005-09-12 2010-10-12 Sharp Kabushiki Kaisha Multiple-view directional display
AU2011213557B2 (en) 2010-02-05 2015-05-07 Phosphagenics Limited Carrier comprising non-neutralised tocopheryl phosphate
WO2011120084A1 (en) 2010-03-30 2011-10-06 Phosphagenics Limited Transdermal delivery patch
WO2012122586A1 (en) 2011-03-15 2012-09-20 Phosphagenics Limited New composition
ES2981002T3 (es) 2015-12-09 2024-10-04 Avecho Biotechnology Ltd Formulación farmacéutica
ES2983921T3 (es) 2016-12-21 2024-10-28 Avecho Biotechnology Ltd Proceso para fosforilar un alcohol complejo

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62205091A (ja) * 1986-03-04 1987-09-09 Senjiyu Seiyaku Kk 新規なリン酸ジエステルならびにその塩、その製造法およびそれを含有する製剤
CA2002649C (en) * 1988-11-14 2000-06-06 Margaret Petty Cardioprotective tocopherol analogs

Also Published As

Publication number Publication date
DE69224501D1 (de) 1998-04-02
KR100253108B1 (ko) 2000-05-01
AU2538392A (en) 1993-04-08
AU652077B2 (en) 1994-08-11
CA2079289A1 (en) 1993-04-03
ZA927429B (en) 1993-04-07
ES2115656T3 (es) 1998-07-01
EP0535283A1 (de) 1993-04-07
HU9203134D0 (en) 1992-12-28
HUT62592A (en) 1993-05-28
CA2079289C (en) 2003-02-18
DK0536036T3 (da) 1998-03-16
NO923840D0 (no) 1992-10-01
FI924424A0 (fi) 1992-10-01
TW224970B (de) 1994-06-11
HU215123B (hu) 1998-09-28
EP0536036B1 (de) 1998-02-25
FI924424A (fi) 1993-04-03
NZ244549A (en) 1994-07-26
GR3026242T3 (en) 1998-05-29
JP3230699B2 (ja) 2001-11-19
JPH05310763A (ja) 1993-11-22
NO923840L (no) 1993-04-05
IL103305A0 (en) 1993-02-21
DE69224501T2 (de) 1998-06-25
FI105552B (fi) 2000-09-15
EP0536036A1 (de) 1993-04-07

Similar Documents

Publication Publication Date Title
ATE163421T1 (de) Tocopherol-analoge mit cardioprotectiver wirkung
ATE269290T1 (de) Benzoylderivate
ATE68495T1 (de) 4,5,6,7-tetrahydro-1h-imidazo(4,5c>pyridinderivate und analoge mit antihypertensiver wirkung.
FI920023A0 (fi) Heteroarylpiperazinfoereningar som antipsykotiska aemnen.
ES2191659T3 (es) Derivados heterociclicos substituidos utiles como inhibidores de la agregacion plaquetaria.
FI882358A0 (fi) Cykliska antikoagulationspeptider.
DE3880194D1 (de) Zyklisches antikoagulierendes peptid.
FI892222A (fi) Peptidalkoholer med antikoagulantverkan.
EP0050286A3 (en) Novel pharmaceutical guanidine derivatives
ATE137230T1 (de) Ascorbinsäure derivate
FI901277A0 (fi) 2,5,6,7-tetranor-4,8-inter-m-fenylen pg1z-derivativ.
ES2086395T3 (es) Fosfolipidos para el tratamiento de esclerosis multiple.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee